Completed PHASE3 INTERVENTIONAL 2-arm NCT02650609

Treatment of Chronic Subdural Hematoma by Corticosteroids (SUCRE)

Sponsor: Rennes University Hospital

Interventions Methylprednisolone Placebo

Updated 10 times since 2017 Last updated: Jun 8, 2020 Started: Jun 24, 2016 Primary completion: Mar 20, 2019 Completion: Mar 20, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Chronic Subdural Hematomas, this trial is completed. The trial is conducted by Rennes University Hospital and has accumulated 10 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jul 2020 — Jan 2021 [monthly]

Completed PHASE3

Status: Recruiting → Completed

▶ Show 5 earlier versions

Apr 2019 — Jul 2020 [monthly]

Recruiting PHASE3
Oct 2018 — Apr 2019 [monthly]

Recruiting PHASE3
Jun 2018 — Oct 2018 [monthly]

Recruiting PHASE3
Sep 2017 — Jun 2018 [monthly]

Recruiting PHASE3
Jan 2017 — Sep 2017 [monthly]

Recruiting PHASE3

First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rennes University Hospital

Data source: Rennes University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amiens, France , Angers, France , Besançon, France , Bordeaux, France , Brest, France , Caen, France , Lille, France , Lyon, France , Marseille, France , Nancy, France and 6 more locations